Connect with us

Hi, what are you looking for?

press release

IDEAYA Biosciences (NASDAQ:IDYA), JPMorgan Chase (NYSE:JPM) – – Press Release

image oracle

With US stock futures trading higher this morning on Monday, some of the stocks that may draw investor focus today include the following:

  • Wall Street expects Oracle Corporation ORCL report quarterly earnings of $1.07 per share on sales of $11.46 billion. Oracle shares are up 0.1% in after-hours trading to $75.99.
  • JPMorgan Chase & Co. JPM agreed to acquire California-based Renovite Technologies to solidify its presence in the payments processing space. JPMorgan shares fell 0.1% to $119.13 in after-hours trading.
  • Analysts expect Matrix Service Company MTRX Posted a quarterly loss of $0.30 per share on revenue of $181.84 million for the most recent quarter. The company will release earnings after the market close. Matrix Service shares fell 0.4% to $5.72 in after-hours trading.

Check out ours premarket coverage here

  • IDEAYA Biosciences, Inc. IDJA published preliminary phase 2 clinical results for the synthetic lethal combination darovasertib and crizotinib in metastatic uveal melanoma. IDEAYA Biosciences shares fell 1% to close at $9.25 on Friday.
  • Analysts expect Rent the Runway, Inc. RENTAL FEE posted a quarterly loss of $0.65 per share on after-market sales of $73.26 million. Rent the Runway shares fell 2% to $4.39 in the after-hours trading session.

Source Story here

You May Also Like

Business

State would join dozens of others in enacting legislation based on federal government’s landmark whistleblower statute, the False Claims Act

press release

With a deep understanding of the latest tech, Erbo helps businesses flourish in a digital world.

press release

#Automotive #Carbon #Canister #Market #Projected #Hit #USD New York, US, Oct. 24, 2022 (GLOBE NEWSWIRE) —  According to a comprehensive research report by Market...

press release

Barrington Research Analyst James C.Goss reiterated an Outperform rating on shares of IMAX Corp IMAX with a Price target of $20. As theaters...